<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116105">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02053168</url>
  </required_header>
  <id_info>
    <org_study_id>DVL-HE-015</org_study_id>
    <nct_id>NCT02053168</nct_id>
  </id_info>
  <brief_title>A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair</brief_title>
  <official_title>A Prospective, Multicenter All Comers Study of a Novel Resorbable Mesh (Phasix Mesh) for Ventral or Incisional Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>C. R. Bard</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>C. R. Bard</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collect data on safety, performance, and effectiveness of Phasix Mesh in subject requiring
      primary ventral and incisional hernias.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Hernia Recurrence Rate</measure>
    <time_frame>12 Months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device related adverse events</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL assessments</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical procedure time</measure>
    <time_frame>10 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital post Index Procedure</measure>
    <time_frame>10 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>10 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of study related post operative surgical procedures and admissions.</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of study related post operative surgical procedure and admissions</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of related post-operative visits unrelated to standard of care</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of seroma</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Ventral Hernia</condition>
  <condition>Incisional Hernia</condition>
  <arm_group>
    <arm_group_label>Phasix Mesh</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phasix Mesh</intervention_name>
    <arm_group_label>Phasix Mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject or subject's legally authorized representative must be willing to give
             written informed consent

          -  Subject must be diagnosed with ventral or incisional hernia

          -  Subject must be willing to undergo open ventral hernia repair and be able to undergo
             all other study procedures as outlined in this protocol.

        Exclusion Criteria:

          -  Subject is an active smoker (if attempts to quit smoking within two weeks of surgery
             have failed and the patient is still an active smoker at the time of surgery).

          -  Subject's hernia has recurred more than once.

          -  Subject's body mass index (BMI) &gt;40 kg/m2.

          -  Subject has peritonitis.

          -  Subject is on or suspected to be placed on chemotherapy medications during any part
             of the study.

          -  Chronic steroid use or immunosuppression drugs (&gt; 6 months).

          -  Subject has cirrhosis, and/or ascites.

          -  Subject is American Society of Anesthesiology Class 4 or 5.

          -  Subject is pregnant or planning to become pregnant during the course of the study.

          -  Subject is known to be infected with human immunodeficiency virus (HIV).

          -  Subject has a life expectancy of less than 2 years at the time of enrollment.

          -  Subject has been treated with an investigational product in the past 30 days.

          -  Subject is part of the site personnel directly involved with this study

          -  Subject has a known allergy to tetracycline hydrochloride or kanamycin sulfate, the
             test device or its component materials.

          -  Subject has any condition that in the opinion of the Investigator would preclude the
             use of the study device, or preclude the subject from completing the follow-up
             requirements
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuri Novitsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Case Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rushil Sankpal</last_name>
    <phone>908-277-8082</phone>
    <email>rushil.sankpal@crbard.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beverly Hills Hernia Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Sarmiento</last_name>
      <phone>310-423-4295</phone>
      <email>Laura.sarmiento@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Shirin Towfigh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Sarmiento</last_name>
      <phone>310-423-4295</phone>
      <email>Laura.sarmiento@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Shirin Towfigh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Celebration Health</name>
      <address>
        <city>Celebration</city>
        <state>Florida</state>
        <zip>34747</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Cartwritght, RN</last_name>
      <phone>407-303-4235</phone>
      <email>Kim.cartwright@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Eduardo Parra Davila, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Seafler, RN</last_name>
      <phone>216-844-4706</phone>
      <email>Christina.seafler@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Yuri Novitsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>January 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
